SCP
AMGN icon

Stamos Capital Partners’s Amgen AMGN Stock Holding History

Stamos Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$679K Sell
1,930
-354
-15% -$126K 0.11% 126
2025
Q4 		$748K Sell
2,284
-324
-12% -$103K 0.12% 125
2025
Q3 		$736K Sell
2,608
-1,532
-37% -$444K 0.14% 116
2025
Q2 		$1.16M Buy
4,140
+449
+12% +$127K 0.21% 109
2025
Q1 		$1.15M Sell
3,691
-3,039
-45% -$897K 0.3% 92
2024
Q4 		$1.75M Buy
6,730
+2,760
+70% +$819K 0.41% 69
2024
Q3 		$1.28M Sell
3,970
-60
-1% -$19.6K 0.3% 80
2024
Q2 		$1.26M Buy
4,030
+170
+4% +$49.9K 0.27% 91
2024
Q1 		$1.1M Sell
3,860
-480
-11% -$140K 0.25% 87
2023
Q4 		$1.25M Sell
4,340
-9,410
-68% -$2.56M 0.34% 70
2023
Q3 		$3.7M Sell
13,750
-1,410
-9% -$352K 0.82% 31
2023
Q2 		$3.37M Buy
15,160
+2,370
+19% +$550K 0.79% 35
2023
Q1 		$3.09M Buy
12,790
+2,550
+25% +$626K 0.8% 39
2022
Q4 		$2.69M Sell
10,240
-3,050
-23% -$818K 0.85% 37
2022
Q3 		$3M Buy
+13,290
New +$3.22M 0.76% 39

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stamos Capital Partners's AMGN Position: Q1 2026 in Review

Stamos Capital Partners reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $126K and leaving 1,930 shares worth $679K. The position accounts for 0.11% of the portfolio, ranked #126.

Stamos Capital Partners first reported a position in AMGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.7M in Q3 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Stamos Capital Partners held 1,930 shares of Amgen worth $679K as of Q1 2026.
  • Stamos Capital Partners sold 354 Amgen shares in Q1 2026, an estimated $126K.
  • Amgen made up 0.11% of Stamos Capital Partners's portfolio in Q1 2026, its #126 holding.
  • Stamos Capital Partners first reported a position in Amgen in Q3 2022 and has held it in 15 quarters since.
  • Stamos Capital Partners's Amgen position peaked at $3.7M in Q3 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.